{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-011774","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.192014+00:00","generated_at":"2026-06-04T06:52:34.410147+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Enveric sets May 28, 2024 Annual Meeting; stockholder proposal deadline April 8, 2024","bullets":["Annual Meeting scheduled for May 28, 2024, more than 30 days after 2023 meeting held Nov 2, 2023.","Stockholder proposals for director nominations must be received by April 8, 2024 at 5:00 PM ET.","Proposals must comply with Enveric's bylaws and SEC rules to be eligible for proxy inclusion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-011774","json":"https://secwatch.observer/filing/0001493152-24-011774.json","markdown":"https://secwatch.observer/filing/0001493152-24-011774.md","text":"https://secwatch.observer/filing/0001493152-24-011774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315224011774/0001493152-24-011774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315224011774/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:52:34.410147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}